Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hollander P et al. – Saxagliptin added to TZD provided statistically significant improvements in key parameters of glycemic control vs. TZD monotherapy and was generally well tolerated.

Related Articles

Study Finds That ONGLYZA (saxagliptin) When Added To Metformin Was Non-Inferior To JANUVIA When Added To Metformin In Reducing Hemoglobin In Adults With Type 2 Diabetes Mellitus
Bristol Myers-Squibb Company, 10/06/09    Relevance Score: 93%

Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes
Current Medical Research and Opinion, 10/02/09    Relevance Score: 93%

Evidence for an association with type 2 diabetes mellitus at the PPARG locus in a South Indian population
Metabolism-Clinical and Experimental, 11/03/09    Relevance Score: 90%

Hepatic fat and inflammation in type 2 diabetes mellitus
Metabolism-Clinical and Experimental, 10/26/09    Relevance Score: 90%

Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study
International Journal of Obesity, 10/16/09    Relevance Score: 90%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address